← Leaderboards
Andrew J Gale
Scripps Research Institute
$1,446,756
Attributed
$1,446,756
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $371.8K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,446,756 · 1
By mechanism
R01$1,446,756 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Lennart Mucke$61,251,241
- David A Cheresh$37,188,318
- Michael B Oldstone$35,619,947
- John H Griffin$36,904,209
- Benjamin F Cravatt$59,198,934
Others in their field
Top investigators on “Hemostatic Function”
- Susan Fera Assmann · New England Research Institutes, Inc.$27,762,151
- Joel S. Bennett · University Of Pennsylvania$25,323,843
- Rod S Passman · Northwestern University$18,589,038
- Mortimer Poncz · University Of Pennsylvania$18,060,270
- Satya P. Kunapuli · Temple University$17,793,609
- David Couper · Univ Of North Carolina Chapel Hill$17,635,956
Research focus
Hemostatic FunctionA MouseHemophilia AHemorrhageBinding (Molecular Function)Cleaved CellAppendixCrosslinkCancer ProcoagulantDefectCharacteristicsDissociationDisulfide BondDisulfidesComplexBiochemicalEndopeptidasesEngineeringCysteineFactor ViiiFactor ViiiaFutureHalf-LifeImagery
Grant awards (4)
Stabilized factor VIIIa as improved therapy for hemophilia A$359,360
R01 · FY2008 · HL · contact PI
Stabilized factor VIIIa as improved therapy for hemophilia A$352,533
R01 · FY2007 · HL · contact PI
Stabilized factor VIIIa as an improved therapy for hemo*$363,063
R01 · FY2006 · HL · contact PI
Stabilized factor VIIIa as therapy for hemophilia A$371,800
R01 · FY2005 · HL